Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Nanus

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Oncogene|November 1, 1991
Transformation of human kidney proximal tubule cells by a src-containing retrovirusD M Nanus, S A Lynch, P H Rao, et al.
Oncogene|January 26, 2006
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cellsJ Gong, J Zhu, O B Goodman, et al.
Cancer Research|April 20, 2001
Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathwayM Sumitomo, M I Milowsky, R Shen, et al.
Oncogene|October 1, 1993
Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanomaF Loganzo, J S Dosik, Y Zhao, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 30, 2008
Modulation of 11beta-hydroxysteroid dehydrogenase expression by bombesin: a possible mechanism for glucocorticoid resistance in androgen independent prostate cancerJ G Lee, R Ge, D O Hardy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancerW K Kelly, I Osman, V E Reuter, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetD O Hardy, H I Scher, T Bogenreider, et al.
The Journal of Urology|November 1, 1996
Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actionsL M Pfeffer, C Wang, S N Constantinescu, et al.
Oncogene|May 3, 2006
Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidaseR Zheng, A Iwase, R Shen, et al.
Oncogene|November 1, 1989
Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotypeA P Albino, D M Nanus, I R Mentle, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Oncogene|November 1, 1991
Transformation of human kidney proximal tubule cells by a src-containing retrovirusD M Nanus, S A Lynch, P H Rao, et al.
Oncogene|January 26, 2006
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cellsJ Gong, J Zhu, O B Goodman, et al.
Cancer Research|April 20, 2001
Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathwayM Sumitomo, M I Milowsky, R Shen, et al.
Oncogene|October 1, 1993
Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanomaF Loganzo, J S Dosik, Y Zhao, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 30, 2008
Modulation of 11beta-hydroxysteroid dehydrogenase expression by bombesin: a possible mechanism for glucocorticoid resistance in androgen independent prostate cancerJ G Lee, R Ge, D O Hardy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancerW K Kelly, I Osman, V E Reuter, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onsetD O Hardy, H I Scher, T Bogenreider, et al.
The Journal of Urology|November 1, 1996
Human renal cancers resistant to IFN's antiproliferative action exhibit sensitivity to IFN's gene-inducing and antiviral actionsL M Pfeffer, C Wang, S N Constantinescu, et al.
Oncogene|May 3, 2006
Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidaseR Zheng, A Iwase, R Shen, et al.
Oncogene|November 1, 1989
Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotypeA P Albino, D M Nanus, I R Mentle, et al.
Pageof 7